SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.

Published on Mar 13, 2017in Cancer Cell26.602
· DOI :10.1016/J.CCELL.2017.02.004
Mirjam Blattner11
Estimated H-index: 11
(Cornell University),
Deli Liu10
Estimated H-index: 10
(Cornell University)
+ 14 AuthorsChristopher E. Barbieri32
Estimated H-index: 32
(Cornell University)
Recurrent point mutations in SPOP define a distinct molecular subclass of prostate cancer. Here, we describe a mouse model showing that mutant SPOP drives prostate tumorigenesis in vivo. Conditional expression of mutant SPOP in the prostate dramatically altered phenotypes in the setting of Pten loss, with early neoplastic lesions (high-grade prostatic intraepithelial neoplasia) with striking nuclear atypia and invasive, poorly differentiated carcinoma. In mouse prostate organoids, mutant SPOP drove increased proliferation and a transcriptional signature consistent with human prostate cancer. Using these models and human prostate cancer samples, we show that SPOP mutation activates both PI3K/mTOR and androgen receptor signaling, effectively uncoupling the normal negative feedback between these two pathways.
Figures & Tables
📖 Papers frequently viewed together
997 Citations
312 Authors (Adam Abeshouse, ..., Erik Zmuda)
1,398 Citations
1,624 Citations
#1Dong Gao (CAS: Chinese Academy of Sciences)H-Index: 21
#2Yu Zhan (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 10
Last. Yu Chen (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 11
view all 12 authors...
Fusion between TMPRSS2 and ERG, placing ERG under the control of the TMPRSS2 promoter, is the most frequent genetic alteration in prostate cancer, present in 40–50% of cases. The fusion event is an early, if not initiating, event in prostate cancer, implicating the TMPRSS2-positive prostate epithelial cell as the cancer cell of origin in fusion-positive prostate cancer. To introduce genetic alterations into Tmprss2-positive cells in mice in a temporal-specific manner, we generated a Tmprss2-CreE...
10 CitationsSource
#1Anna C. Groner (Harvard University)H-Index: 16
#2Laura Cato (Harvard University)H-Index: 9
Last. Myles Brown (Harvard University)H-Index: 113
view all 22 authors...
Androgen receptor (AR) signaling is a key driver of prostate cancer (PC). While androgen-deprivation therapy is transiently effective in advanced disease, tumors often progress to a lethal castration-resistant state (CRPC). We show that recurrent PC-driver mutations in speckle-type POZ protein (SPOP) stabilize the TRIM24 protein, which promotes proliferation under low androgen conditions. TRIM24 augments AR signaling, and AR and TRIM24 co-activated genes are significantly upregulated in CRPC. Ex...
117 CitationsSource
#1Wendy K. Pierce (St. Jude Children's Research Hospital)H-Index: 1
#2Christy R. Grace (St. Jude Children's Research Hospital)H-Index: 25
Last. Tanja Mittag (St. Jude Children's Research Hospital)H-Index: 25
view all 10 authors...
Primary sequence motifs, with millimolar affinities for binding partners, are abundant in disordered protein regions. In multivalent interactions, such weak linear motifs can cooperate to recruit binding partners via avidity effects. If linear motifs recruit modifying enzymes, optimal placement of weak motifs may regulate access to modification sites. Weak motifs may thus exert physiological relevance stronger than that suggested by their affinities, but molecular mechanisms of their function ar...
22 CitationsSource
#1Juan Antonio Vizcaíno (EMBL-EBI: European Bioinformatics Institute)H-Index: 51
#2Attila Csordas (EMBL-EBI: European Bioinformatics Institute)H-Index: 20
Last. Henning Hermjakob (Protein Sciences)H-Index: 82
view all 13 authors...
The PRoteomics IDEntifications (PRIDE) database is one of the world-leading data repositories of mass spectrometry (MS)-based proteomics data. Since the beginning of 2014, PRIDE Archive (http://www.ebi.ac.uk/pride/archive/) is the new PRIDE archival system, replacing the original PRIDE database. Here we summarize the developments in PRIDE resources and related tools since the previous update manuscript in the Database Issue in 2013. PRIDE Archive constitutes a complete redevelopment of the origi...
2,675 CitationsSource
#1Adam Abeshouse (NIH: National Institutes of Health)H-Index: 14
#2Jaeil Ahn (NIH: National Institutes of Health)H-Index: 20
Last. Erik Zmuda (NIH: National Institutes of Health)H-Index: 9
view all 312 authors...
Summary There is substantial heterogeneity among primary prostate cancers, evident in the spectrum of molecular abnormalities and its variable clinical course. As part of The Cancer Genome Atlas (TCGA), we present a comprehensive molecular analysis of 333 primary prostate carcinomas. Our results revealed a molecular taxonomy in which 74% of these tumors fell into one of seven subtypes defined by specific gene fusions ( ERG , ETV1/4 , and FLI1 ) or mutations ( SPOP , FOXA1 , and IDH1 ). Epigeneti...
1,398 CitationsSource
#1Jian An (Mayo Clinic)H-Index: 13
#2Shancheng Ren ('SMMU': Second Military Medical University)H-Index: 29
Last. Haojie Huang (Mayo Clinic)H-Index: 45
view all 23 authors...
SPOP mutations and TMPRSS2-ERG rearrangements occur collectively in up to 65% of human prostate cancers. Although the two events are mutually exclusive, it is unclear whether they are functionally interrelated. Here, we demonstrate that SPOP, functioning as an E3 ubiquitin ligase substrate-binding protein, promotes ubiquitination and proteasome degradation of wild-type ERG by recognizing a degron motif at the N terminus of ERG. Prostate cancer-associated SPOP mutations abrogate the SPOP-mediated...
83 CitationsSource
#1Wenjian Gan (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 19
#2Xiangpeng Dai (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 18
Last. Wenyi Wei (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 67
view all 15 authors...
The ERG gene is fused to TMPRSS2 in approximately 50% of prostate cancers (PrCa), resulting in its overexpression. However, whether this is the sole mechanism underlying ERG elevation in PrCa is currently unclear. Here we report that ERG ubiquitination and degradation are governed by the Cullin 3-based ubiquitin ligase SPOP and that deficiency in this pathway leads to aberrant elevation of the ERG oncoprotein. Specifically, we find that truncated ERG (ΔERG), encoded by the ERG fusion gene, is st...
109 CitationsSource
#1Gunther Boysen (Cornell University)H-Index: 18
#2Christopher E. Barbieri (Cornell University)H-Index: 32
Last. Mark A. RubinH-Index: 157
view all 20 authors...
Prostate cancer is the most common type of cancer in men in the UK and USA. Cancers develop when cells in the body acquire genetic mutations that allow the cells to grow rapidly and form a mass known as a tumor. Prostate cancer cells from different individuals can carry different genetic mutations, which affects whether the disease progresses and how the tumors respond to medical treatments. This genetic variety arises in cancer cells partly from a phenomenon known as genomic instability, in whi...
84 CitationsSource
#1Jonathan F. Goodwin (Thomas Jefferson University)H-Index: 8
#2Vishal Kothari (UM: University of Michigan)H-Index: 20
Last. Karen E. Knudsen (Thomas Jefferson University)H-Index: 68
view all 29 authors...
Summary Emerging evidence demonstrates that the DNA repair kinase DNA-PKcs exerts divergent roles in transcriptional regulation of unsolved consequence. Here, in vitro and in vivo interrogation demonstrate that DNA-PKcs functions as a selective modulator of transcriptional networks that induce cell migration, invasion, and metastasis. Accordingly, suppression of DNA-PKcs inhibits tumor metastases. Clinical assessment revealed that DNA-PKcs is significantly elevated in advanced disease and indepe...
99 CitationsSource
#1Dan R. Robinson (UM: University of Michigan)H-Index: 54
#2Eliezer M. Van Allen (MIT: Massachusetts Institute of Technology)H-Index: 71
Last. Arul M. ChinnaiyanH-Index: 160
view all 73 authors...
Summary Toward development of a precision medicine framework for metastatic, castration-resistant prostate cancer (mCRPC), we established a multi-institutional clinical sequencing infrastructure to conduct prospective whole-exome and transcriptome sequencing of bone or soft tissue tumor biopsies from a cohort of 150 mCRPC affected individuals. Aberrations of AR , ETS genes, TP53 , and PTEN were frequent (40%–60% of cases), with TP53 and AR alterations enriched in mCRPC compared to primary prosta...
1,624 CitationsSource
Cited By77
#1Lauren K Jillson (Anschutz Medical Campus)H-Index: 1
#2Gabriel A Yette (Anschutz Medical Campus)
Last. Scott D. Cramer (Anschutz Medical Campus)H-Index: 36
view all 0 authors...
While many prostate cancer (PCa) cases remain indolent and treatable, others are aggressive and progress to the metastatic stage where there are limited curative therapies. Androgen receptor (AR) signaling remains an important pathway for proliferative and survival programs in PCa, making disruption of AR signaling a viable therapy option. However, most patients develop resistance to AR-targeted therapies or inherently never respond. The field has turned to PCa genomics to aid in stratifying hig...
The CREB-binding protein (CBP) and p300 are two paralogous lysine acetyltransferases (KATs) that were discovered in the 1980s–1990s. Since their discovery, CBP/p300 have emerged as important regulatory proteins due to their ability to acetylate histone and non-histone proteins to modulate transcription. Work in the last 20 years has firmly established CBP/p300 as critical regulators for nuclear hormone signaling pathways, which drive tumor growth in several cancer types. Indeed, CBP/p300 are cri...
53BP1 activates nonhomologous end joining (NHEJ) and inhibits homologous recombination (HR) repair of DNA double-strand breaks (DSBs). Dissociation of 53BP1 from DSBs and consequent activation of HR, a less error-prone pathway than NHEJ, helps maintain genome integrity during DNA replication; however, the underlying mechanisms are not fully understood. Here, we demonstrate that E3 ubiquitin ligase SPOP promotes HR during S phase of the cell cycle by excluding 53BP1 from DSBs. In response to DNA ...
#1Geniver El Tekle (USI: University of Lugano)H-Index: 2
#2Tiziano Bernasocchi (USI: University of Lugano)H-Index: 4
Last. Jean-Philippe Theurillat (USI: University of Lugano)H-Index: 4
view all 7 authors...
Cancer is the dysregulated proliferation of cells caused by acquired mutations in key driver genes. The most frequently mutated driver genes promote tumorigenesis in various organisms, cell types, and genetic backgrounds. However, recent cancer genomics studies also point to the existence of context-dependent driver gene functions, where specific mutations occur predominately or even exclusively in certain tumor types or genetic backgrounds. Here, we review examples of co-occurring and mutually ...
#1Deli LiuH-Index: 10
#2Michael A. Augello (Cornell University)H-Index: 16
Last. Christopher E. Barbieri (Cornell University)H-Index: 32
view all 14 authors...
BACKGROUNDMolecular characterization of prostate cancer (PCa) has revealed distinct subclasses based on underlying genomic alterations occurring early in the natural history of the disease. However, how these early alterations influence subsequent molecular events and the course of the disease over its long natural history remains unclear.METHODSWe explored the molecular and clinical progression of different genomic subtypes of PCa using distinct tumor lineage models based on human genomic and t...
#1Emery T. Usher (PSU: Pennsylvania State University)H-Index: 1
#2Nafiseh Sabri (St. Jude Children's Research Hospital)H-Index: 1
Last. Scott A. Showalter (PSU: Pennsylvania State University)H-Index: 22
view all 6 authors...
Abstract Speckle-type POZ protein (SPOP) is a ubiquitin ligase adaptor that binds substrate proteins and facilitates their proteasomal degradation. Most SPOP substrates present multiple SPOP-binding motifs and undergo liquid-liquid phase separation with SPOP. Pancreatic and duodenal homeobox 1 (Pdx1), an insulin transcription factor, is downregulated by interaction with SPOP. Unlike other substrates, however, Pdx1 was reported to have just one SPOP-binding (SB) motif within its C-terminal disord...
#1Alok K. Tewari (Harvard University)H-Index: 12
#2Alexander CheungH-Index: 1
view all 20 authors...
High-risk localized prostate cancer (HRLPC) is associated with a substantial risk of recurrence and prostate cancer-specific mortality1. Recent clinical trials have shown that intensifying anti-androgen therapies administered prior to prostatectomy can induce pathologic complete responses (pCR) or minimal residual disease (MRD) (<5 mm), together termed exceptional response, although the molecular determinants of these clinical outcomes are largely unknown. Here, we performed whole exome (WES) an...
#1Carley Snoznik (University of Pittsburgh)H-Index: 2
#1C. Snoznik (NU: Northwestern University)
Last. Todd LamitinaH-Index: 8
view all 7 authors...
A hexanucleotide repeat expansion in the C9orf72 gene is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Unconventional translation of the C9orf72 repeat produces dipeptide repeat proteins (DPRs). Previously, we showed that the DPRs (PR)50 and (GR)50 are highly toxic when expressed in C. elegans and this toxicity depends on nuclear localization of the DPR. In an unbiased genome-wide RNAi screen for suppressors of (PR)50 toxicity, we ident...
#1Kumar Nikhil (Purdue University)H-Index: 15
#2Hanan S. Haymour (Purdue University)H-Index: 2
Last. Kavita Shah (Purdue University)H-Index: 45
view all 4 authors...
SPOP, an E3 ubiquitin ligase adaptor, can act either as a tumour suppressor or a tumour promoter. In prostate cancer (PCa), it inhibits tumorigenesis by degrading several oncogenic substrates. SPOP is the most altered gene in PCa (~15%), which renders it ineffective, promoting cancer. The remaining PCa tumours, which retain WT-SPOP, still progress to castration-resistant (CRPC) stage, indicating that other critical mechanisms exist for downregulating SPOP. SPOP is reduced in ~94% of WT-SPOP-bear...
#1Dannah R. Miller (UNMC: University of Nebraska Medical Center)H-Index: 5
#2Matthew A. Ingersoll (UNMC: University of Nebraska Medical Center)H-Index: 1
Last. Ming Fong LinH-Index: 39
view all 4 authors...
Prostate cancer (PCa) is the most commonly diagnosed solid tumor and the second leading cause of cancer-related deaths in U.S. men in 2020. Androgen-deprivation therapy (ADT) is the standard of care for metastatic PCa. Unfortunately, PCa relapse often occurs one to two years after initiation of ADT, resulting in the development of castration-resistant PCa (CRPCa), a lethal disease. While several anticancer agents such as docetaxel, abiraterone acetate, and enzalutamide are currently utilized to ...